CompaniesGamamabs Pharma

Gamamabs Pharma

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

143

By Phase

PHASE2: 1PHASE1: 1

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2015

2016

2017

2018

2019

2020

2021

2022

Today

Hover over trial bars to see details

Recent Trials

NCT03799731Lead Sponsor

Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers

PHASE2Completed

65 participants

Started: Jul 11, 2018 · Completed: Feb 10, 2021

NCT02978755Lead Sponsor

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

PHASE1Completed

78 participants

Started: Jun 30, 2016 · Completed: Jun 10, 2020

Related Companies

Exelixis

acquired